Find verified Deucravacitinib API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Deucravacitinib for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Deucravacitinib API.
Alternate Names: Sotyktu
CAS No: 1609392-27-9
PubChem CID: 134821691
Mol Formula: C20H22N8O3
Mol Weight: 425.5 g/mol
IUPAC Name: 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
Therapeutic use: Anti-inflammatories, Anti-psoriatic agents
Drug Class: JAK inhibitors
Commercial / Development Status: Commercial APIs
Source / Manufacturing Origin: Synthetic APIs
API Description: Deucravacitinib is a novel oral selective tyrosine kinase 2 (TYK2) inhibitor. Unlike other Janus kinase 1/2/3 inhibitors that bind to the conserved active domain of these non-receptor tyrosine kinases, deucravacitinib binds to the regulatory domain of TYK2 with high selectivity to this therapeutic target.
